Scientists have produced new, effective and simplified forms of teixobactin — a new generation antibiotic which defeats multi-drug resistant infections such as MRSA — as part of a pioneering research effort to tackle antimicrobial resistance.
Scientists have produced new, effective and simplified forms of teixobactin — a new generation antibiotic which defeats multi-drug resistant infections such as MRSA — as part of a pioneering research effort to tackle antimicrobial resistance.